Stevanato Group SpA STVN

Morningstar Rating
$19.98 −1.00 (4.77%)
View Full Chart

Company Report

Price vs Fair Value

STVN is trading at a LOCK|hJSGPcq premium.
Price
$19.98
Fair Value
LOCK|.?
Uncertainty
LOCK|y$x
1-Star Price
LOCK|.MH
5-Star Price
LOCK|.S##
Economic Moat
LOCK|p?<%b
Capital Allocation
LOCK|pw<pD%$

Bulls Say, Bears Say

Bulls

Secular tailwinds—including the rise of biologics, peptide therapy adoption, and a shift from intravenous to subcutaneous administration—support long-term injectable demand growth.

Bears

Industrywide capacity expansion raises the risk of oversupply should biologics demand disappoint, which could trigger pricing pressure and margin compression across the packaging industry.

News

Trading Information

Previous Close Price
$20.98
Day Range
$19.51–20.80
52-Week Range
$12.89–27.99
Bid/Ask
$19.45 / $26.00
Shares Outstanding
273.13M
Market Cap
$5.46B
Volume/Avg
202,848 / 369,858

Key Statistics

Price/Earnings (Normalized)
33.18
Price/Sales
3.82
Dividend Yield (Trailing)
0.31%
Dividend Yield (Forward)
0.31%
Dividend Payment Schedule
Jul
Total Yield
0.31%

Company Profile

Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Mid Growth
Total Number of Employees
5,795

Competitors

Valuation

Metric
STVN
YPSN
WST
Price/Earnings (Normalized)
33.1827.2842.94
Price/Book Value
3.086.348.59
Price/Sales
3.826.727.93
Price/Cash Flow
18.4819.1834.37
Price/Earnings
STVN
YPSN
WST

Financial Strength

Metric
STVN
YPSN
WST
Quick Ratio
1.080.741.79
Current Ratio
1.611.072.82
Interest Coverage
33.8776.55150.98
Quick Ratio
STVN
YPSN
WST

Profitability

Metric
STVN
YPSN
WST
Return on Assets (Normalized)
6.21%13.64%14.96%
Return on Equity (Normalized)
10.50%23.71%20.28%
Return on Invested Capital (Normalized)
8.24%18.06%18.06%
Return on Assets
STVN
YPSN
WST

Medical Instruments & Supplies Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Intuitive Surgical Inc
ISRG
LOCK|fFhq<$<MLOCK|xJ$142B
Becton Dickinson & Co
BDX
LOCK|x#ZLOCK|&?gjW$49B
ResMed Inc
RMD
LOCK|wntFydgLOCK|Sv>>^$32B
Medline Inc Ordinary Shares - Class A
MDLN
LOCK|#LVvkYLOCK|#?kn?$31B
Alcon Inc
ALC
LOCK|zPS?<?wLOCK|%ft%M$31B
West Pharmaceutical Services Inc
WST
LOCK|#DkJgYxLOCK|B>p$26B
Solventum Corp
SOLV
LOCK|%%D$CsLOCK|sB@$15B
Baxter International Inc
BAX
LOCK|v%#LOCK|?p<G$12B
The Cooper Companies Inc
COO
LOCK|@FP!k>jLOCK|<WWT!$11B
Align Technology Inc
ALGN
LOCK|$SQC^^@LOCK|M$L#C$10B

Sponsor Center